REPAMADE V1/0.3 TABLET

Product Description

REPAMADE V1/0.3 TABLET | Repaglinide (1mg) + Voglibose (0.3mg)Boost your pharmaceutical portfolio with REPAMADE V1/0.3 TABLET, a powerful combination therapy designed for effective management of Type 2 Diabetes Mellitus. This formulation combines Repaglinide (1mg), a fast-acting insulin secretagogue, with Voglibose (0.3mg), an alpha-glucosidase inhibitor, to provide dual-action glucose control by stimulating insulin release and delaying carbohydrate absorption.Key Benefits: Rapid and sustained postprandial blood glucose control Improved glycemic management with reduced risk of hypoglycemia Enhanced patient compliance due to combined formulation Suitable for adjunct therapy alongside diet and exercise Usage: Prescribed primarily for Type 2 diabetic patients requiring efficient post-meal blood sugar regulation. REPAMADE V1/0.3 TABLET helps optimize insulin secretion and delays glucose absorption to maintain balanced blood sugar levels.Why Choose REPAMADE V1/0.3 TABLET? Ideal for pharmaceutical distributors, retailers, and bulk buyers seeking high-quality antidiabetic solutions. Manufactured under stringent quality standards, REPAMADE ensures efficacy, safety, and consistency critical for large-scale supply in hospitals, clinics, and retail pharmacies.